- Home
- BDSX vs RLTY Comparison
BDSX vs RLTY Comparison
Compare BDSX & RLTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- RLTY
- Stock Information
- Founded
- BDSX 2005
- RLTY 2022
- Country
- BDSX United States
- RLTY United States
- Employees
- BDSX N/A
- RLTY N/A
- Industry
- BDSX Precision Instruments
- RLTY Investment Managers
- Sector
- BDSX Health Care
- RLTY Finance
- Exchange
- BDSX Nasdaq
- RLTY Nasdaq
- Market Cap
- BDSX 245.3M
- RLTY 256.4M
- IPO Year
- BDSX 2020
- RLTY N/A
- Fundamental
- Price
- BDSX $1.66
- RLTY $16.69
- Analyst Decision
- BDSX Strong Buy
- RLTY
- Analyst Count
- BDSX 4
- RLTY 0
- Target Price
- BDSX $3.08
- RLTY N/A
- AVG Volume (30 Days)
- BDSX 238.6K
- RLTY 86.7K
- Earning Date
- BDSX 11-05-2024
- RLTY 01-01-0001
- Dividend Yield
- BDSX N/A
- RLTY 9.35%
- EPS Growth
- BDSX N/A
- RLTY N/A
- EPS
- BDSX N/A
- RLTY N/A
- Revenue
- BDSX $60,902,000.00
- RLTY N/A
- Revenue This Year
- BDSX $48.06
- RLTY N/A
- Revenue Next Year
- BDSX $29.97
- RLTY N/A
- P/E Ratio
- BDSX N/A
- RLTY N/A
- Revenue Growth
- BDSX 46.25
- RLTY N/A
- 52 Week Low
- BDSX $1.15
- RLTY $11.38
- 52 Week High
- BDSX $2.21
- RLTY $14.60
- Technical
- Relative Strength Index (RSI)
- BDSX 43.43
- RLTY 51.14
- Support Level
- BDSX $1.65
- RLTY $16.22
- Resistance Level
- BDSX $1.71
- RLTY $17.28
- Average True Range (ATR)
- BDSX 0.07
- RLTY 0.30
- MACD
- BDSX -0.01
- RLTY -0.12
- Stochastic Oscillator
- BDSX 34.62
- RLTY 37.94
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest
Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.